Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Checkmate Pharmaceuticals, Inc. (CMPI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/31/2022 |
4
| POWELL MICHAEL (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 30,000 options to buy
@ $5.19, valued at
$155.7k
Disposed/sold 10,030 options to buy
@ $6.27, valued at
$62.9k
Disposed/sold 30,000 options to buy
@ $10.95, valued at
$328.5k
|
|
| 05/31/2022 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 10,030 options to buy
@ $6.27, valued at
$62.9k
Disposed/sold 4,012 options to buy
@ $2.47, valued at
$9.9k
Disposed/sold 22,736 options to buy
@ $2.62, valued at
$59.6k
|
|
| 05/31/2022 |
4
| Isacoff Oren (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 10,030 options to buy
@ $6.27, valued at
$62.9k
Disposed/sold 20,000 options to buy
@ $10.95, valued at
$219k
|
|
| 05/31/2022 |
4
| Colabuono Peter (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 10,030 options to buy
@ $6.27, valued at
$62.9k
Disposed/sold 20,000 options to buy
@ $10.95, valued at
$219k
|
|
| 05/31/2022 |
4
| Yan Joy (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 20,061 options to buy
@ $3.12, valued at
$62.6k
|
|
| 05/31/2022 |
4
| Dolski Robert (CFO) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 101,180 options to buy
@ $2.05, valued at
$207.4k
Disposed/sold 27,300 options to buy
@ $5.09, valued at
$139k
Disposed/sold 150,000 options to buy
@ $14.84, valued at
$2.2M
|
|
| 05/31/2022 |
4
| Wooldridge James (Chief Medical Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 54,600 options to buy
@ $13.5, valued at
$737.1k
Disposed/sold 101,180 options to buy
@ $2.05, valued at
$207.4k
Disposed/sold 27,300 options to buy
@ $5.09, valued at
$139k
Disposed/sold 150,818 options to buy
@ $15, valued at
$2.3M
Disposed/sold 95,916 options to buy
@ $2.62, valued at
$251.3k
|
|
| 05/31/2022 |
4
| Wigginton Jon Marc (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 20,061 options to buy
@ $2.19, valued at
$43.9k
|
|
| 05/31/2022 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 246,671 options to buy
@ $3.93, valued at
$969.4k
Disposed/sold 10,030 options to buy
@ $6.27, valued at
$62.9k
Disposed/sold 22,736 options to buy
@ $2.62, valued at
$59.6k
|
|
| 05/31/2022 |
4
| BASH ALAN (CEO) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 575,000 options to buy
@ $2.99, valued at
$1.7M
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 20,743 shares
@ $10.37, valued at
$215.1k
Sold 48,334 shares
@ $10.3702, valued at
$501.2k
Sold 17,600 shares
@ $10.374, valued at
$182.6k
|
|
| 05/04/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 153,700 shares
@ $10.3837, valued at
$1.6M
Sold 79,475 shares
@ $10.3735, valued at
$824.4k
Sold 37,500 shares
@ $10.3713, valued at
$388.9k
|
|
| 04/29/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 47,396 shares
@ $10.3802, valued at
$492k
Sold 73,400 shares
@ $10.3806, valued at
$761.9k
Sold 69,230 shares
@ $10.3808, valued at
$718.7k
|
|
| 04/28/2022 |
4
| Wooldridge James (Chief Medical Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 54,600 options to buy
@ $13.5, valued at
$737.1k
|
|
| 04/26/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 37,430 shares
@ $10.3883, valued at
$388.8k
Sold 27,668 shares
@ $10.3876, valued at
$287.4k
Sold 64,683 shares
@ $10.3823, valued at
$671.6k
|
|
| 04/21/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 399,923 shares
@ $10.4151, valued at
$4.2M
Sold 85,611 shares
@ $10.3887, valued at
$889.4k
Sold 62,200 shares
@ $10.3837, valued at
$645.9k
|
|
| 03/02/2022 |
4
| BASH ALAN (CEO) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 575,000 options to buy
@ $2.99, valued at
$1.7M
|
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Wigginton Jon Marc (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 20,061 options to buy
@ $2.19, valued at
$43.9k
|
|
| 01/31/2022 |
4
| Dolski Robert (CFO) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 101,180 options to buy
@ $2.05, valued at
$207.4k
|
|
| 01/31/2022 |
4
| Wooldridge James (Chief Medical Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 101,180 options to buy
@ $2.05, valued at
$207.4k
|
|
| 12/17/2021 |
4
| Yan Joy (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 20,061 options to buy
@ $3.12, valued at
$62.6k
|
|
| 10/29/2021 |
4
| Fuhrman Alan (See Remarks) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 246,671 options to buy
@ $3.93, valued at
$969.4k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2021 |
4
| Dolski Robert (CFO) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 27,300 options to buy
@ $5.09, valued at
$139k
|
|
| 08/06/2021 |
4
| Chaudhary Kleem (Chief Business Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 27,300 options to buy
@ $5.09, valued at
$139k
|
|
| 08/06/2021 |
4
| Wooldridge James (Chief Medical Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 27,300 options to buy
@ $5.09, valued at
$139k
|
|
| 08/06/2021 |
4
| Labinger Barry (President and CEO) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 85,950 options to buy
@ $5.09, valued at
$437.5k
|
|
| 06/21/2021 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 10,030 options to buy
@ $6.27, valued at
$62.9k
|
|
| 06/21/2021 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 10,030 options to buy
@ $6.27, valued at
$62.9k
|
|
| 06/21/2021 |
4
| Isacoff Oren (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 10,030 options to buy
@ $6.27, valued at
$62.9k
|
|
| 06/21/2021 |
4
| Colabuono Peter (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 10,030 options to buy
@ $6.27, valued at
$62.9k
|
|
|
|
|